Farm Progress links rising beef demand to GLP-1 users, an unexpected ripple from the weight loss drug boom into agriculture.
Recap by typeshit. Full story at Farm Progress.
The EMA's CHMP amended its type 2 diabetes indication, and Italian diabetologists say Italy could be the first European country to offer the once-weekly combo.
26:19
A personal update from TakingWeightOff on life after stopping tirzepatide, three weeks in, and what caught them off guard.
Nyah Phengsitthy reports Lilly is staking out a new battlefront around an unapproved obesity treatment. The full story has the details.
A history of drug advertising, from opium-laced tonics and Radithor to the 1938 law after Elixir Sulfanilamide killed over 100 people. Semaglutide is mostly a hook.
The UCL-led study, mostly on tirzepatide, reported 91.4% of women still on treatment at six months. SheMed, the company running the program, co-authored it.
Over 52 weeks, the 36 mg dose of Lilly's daily pill lowered HbA1c by 2.1% and weight by 8%, with 14% stopping over side effects, mostly GI.
Loading…